Convergent Therapeutics to use $90M funding to treat cancer with radiopharmaceuticals 

Published on May 12, 2023

Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, today announced the completion of a $90 million Series A financing. The funding was led by OrbiMed and RA Capital Management with participation from Invus. The financing will support the development of a pipeline of novel […]

The post Convergent Therapeutics to use $90M funding to treat cancer with radiopharmaceuticals  appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Continue reading on website
Other news

The biggest private biotech investments in April 2023

May 12, 2023
April 2023 saw the companies Orbital Therapeutics, Sangon Biotech, and Alentis Therapeutics bag the biggest biotech investments of the month. Around the world, oncology, drug discovery, food and biomaterials attracted the biggest funding rounds. With reports of venture capital investments in biotech and pharma hitting a more than three-year low last quarter, private biotech fundraising […]The post

New DNA testing technology shows majority of wild dingoes are pure, not hybrids

June 15, 2023
Genetic analysis shows dingo populations have significantly less dog ancestry than previously thought.